Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zihua Xiaoying Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of Hashimoto's thyroiditis complicated by thyroid nodules, particularly those characterized by the phlegm and blood stasis pattern. The decoction is used to reduce thyroid nodule size and modulate autoimmune responses, specifically targeting elevated thyroid autoantibodies such as thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TGAb). It is primarily studied and utilized at Weishan People's Hospital. In TCM theory, the formula works by resolving phlegm, removing blood stasis, and softening hardness to dissipate nodules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zihua xiaoying decoction.